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An ophthalmologist working in Wuhan, China, was among WKHȴUVWWRUHFRJQLVHWKH
possible emergence of a new 
respiratory disease outbreak.3 
Sadly, he and a number of his 
colleagues subsequently died from the infection. 
It is now understood that severe acute respiratory 
syndrome coronavirus 2 (SARS-CoV-2), the virus that 
causes Coronavirus Disease 2019 (COVID-19), is 
transmitted by droplets, aerosol particles, human-to-
human contact or via fomites (particles of skin cells, 
hair, clothing and bedding). Infection can occur when 
viral particles enter the mouth, nose or eyes.4 
To help stop the spread of infection, some measures 
have been implemented in many countries. These 
include:
• Self-isolating measures, i.e., staying at home.5 This 
is particularly important for people considered 
to be vulnerable, i.e. more at risk of severe 
COVID-19 complications. They include older 
people, those with underlying medical problems 
(e.g., diabetes and chronic respiratory, heart, 
kidney, neurological and liver diseases), people 
who are immunosuppressed, and people with 
marked obesity (body mass index [BMI] > 40).6 
Many countries are currently asking their whole 
population to stay at home, with the exception of 
key workers and essential activities, to limit the 
spread of the virus and the number of people 
likely to need intensive care. 
• Social distancing. If people do have to go outside 
of the home, they are advised to keep a distance 
of at least 2 metres from others.7
• People who might have had a travel history or 
possible contact with an infected person are asked 
to self-isolate or are quarantined.8 
Health care workers, especially in a hospital setting, 
DUHRQWKHIURQWOLQHLQWKHH΍RUWVDJDLQVWWKLV
pandemic.9–11 There is considerable concern in the 
ophthalmic community about the risk of infection 
as there is increasing information that the initial 
infectious dose (amount of virus transmitted) and 
resulting high viral load may increase the risk of 
severe COVID-19 disease.12,13
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Protecting yourself and your patients 
from COVID-19 in eye care  
The COVID-19 pandemic 
is having profound 
repercussions around 
the world.1,2 Eye health 
care providers, along 
with other health 
services, are having 
to work out how care 
should now be delivered.
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Guidelines and useful websites
• World Health Organization (WHO). Country 
& Technical Guidance – Coronavirus disease 
(COVID-19)14 
• World Health Organization (WHO). Rational 
use of personal protective equipment for 
coronavirus disease (COVID-19)15
• International Agency for the Prevention of 
Blindness. COVID-19 Resources: Here is what 
we know16
• International Council for Ophthalmology. 
Coronavirus Information for Ophthalmologists17
• Royal College of Ophthalmologists COVID-19 
Clinical Guidelines18 
• American Academy of Ophthalmologists. 
Coronavirus and Eye Care19
• World Council of Optometry. Statement 
concerning COVID-1920
• Centers for Disease Control (US) Strategies 
to Optimise the Supply of PPE21
(GXFDWLQJWKHSXEOLFDERXW&29Ζ'LVDQHVVHQWLDOFRPSRQHQWRI
LQWHUYHQWLRQVWRVWRSWKHVSUHDGRIWKHQRYHOFRURQDYLUXV0$/$:Ζ
There are a number of guidelines on how to adapt 
services and adjust practice to limit the spread of 
infection in a clinical setting; however, the evidence 
LVVWLOOOLPLWHG7KLVXQFHUWDLQW\WKHPDQ\GL΍HUHQFHV
between countries and individual clinical settings, 
and ongoing practical challenges such as shortages 
in personal protective equipment (PPE) means that 
things will be changing all the time and eye health 
workers will have to adapt and make the best of what 
is available to them at the time.
*XLGHOLQHVDUHDOVRFKDQJLQJFRQVWDQWO\WRUHȵHFW
new research as it comes in. We encourage you 
to visit the websites given in the panel to receive 
further updates. The Centers for Disease Control (CDC) 
provides guidance for dealing with PPE shortages at 
https://bit.ly/PPEguide.
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7KHSDUWLFXODUFRQWH[WRIDQH\HKHDOWKVHUYLFHZLOOLQȵXHQFHKRZWKH
guidelines can be put into practice, such as the availability of personal 
protective equipment (PPE), access to emergency care for known 
COVID-19 patients, and the available means of communication.
The current guidelines can be summarised as follows: 
1 Cease providing any routine eye services other than urgent 
or emergency care
2 Protect health care workers
3 Reduce transmission to other patients, and between patients 
and health care workers 
1. Cease providing any routine eye services other 
than urgent or emergency care
Postpone or defer any non-urgent eye appointments. Patients 
coming to an eye clinic or eye unit are at risk of exposure to 
COVID-19 infection, and many patients attending for eye care are 
HOGHUO\RUVX΍HUIURPXQGHUO\LQJFKURQLFPHGLFDOFRQGLWLRQVVXFK
as diabetes; they are at increased risk of severe COVID-19 and 
social distancing is therefore particularly important for them. 
Also, reducing eye care services can release health workers to be 
deployed to other areas of health care where they may be able to 
play an important role during the pandemic.
Where there is an appointment system in place, defer pre-existing 
appointments by text message/phone message, letter or other 
means, as available. Conducting a telephone consultation 
may be helpful to give advice or, if necessary, decide whether 
a face-to-face review is essential. When issuing a prescription, 
follow local guidelines. Ideally, send patients written information 
about any appointment deferrals, the advice given and how new 
appointments will be made once the situation allows. If possible, 
set up pathways for urgent/emergency care together with 
measures to reduce transmission, as discussed in this article. 
Tell patients how they can gain access to such care. 
Patients needing urgent or emergency care
There will be patients who need to be seen and treated urgently. 
Services should continue to be provided, where possible, to 
patients at high risk of visual loss without treatment. This may 
include people with the conditions such as these18,22: 
• Exudative age-related macular degeneration 
• Severe diabetic retinopathy 
• Acute retinal detachment
• Advanced or rapidly progressive glaucoma 
• Severe, active uveitis 
• Serious ocular oncology conditions
• Retinopathy of prematurity (screening and treatment) 
• *OREHUXSWXUHRURWKHUVLJQLȴFDQWWUDXPD
• Serious ocular infections (microbial keratitis, endophthalmitis)
Whether it is appropriate for patients to be seen for urgent/emergency 
H\HFDUHZLOOGHSHQGRQWKHLQGLYLGXDOSDWLHQWWKHULVNRIVLJQLȴFDQW
harm if treatment is delayed and the situation of the eye care 
provider. Having only one seeing eye would be a strong factor in 
favour of a patient being seen, for example. If possible, patients should 
stay away from eye health care settings if they are older than 70 years, 
have serious pre-existing health problems, or are immunosuppressed. 
Table 1 gives some guidance on triaging patients and the 
appropriate precautions to take.
Clinical situation 3DWLHQWPDQDJHPHQWbSUHFDXWLRQV
1. Routine ophthalmic issues and 
previously scheduled 
appointments
• Routine problems should be deferred, and previously scheduled appointments should be cancelled
• Appointments should be rescheduled only upon clearance from public health authorities
• 5HȴOODOOQHFHVVDU\PHGLFDWLRQV
2.Urgent ophthalmology 
appointment for a patient with no 
respiratory illness symptoms, no 
fever, and no COVID-19 risk factors
• Standard precautions*
• Added precaution of not speaking during slit-lamp biomicroscopic examinations is appropriate
• In the setting of adequate PPE supplies, use of surgical mask and eye protection** for the clinician as well as 
surgical mask for the patient may reduce asymptomatic and pre-symptomatic transmission
b8UJHQWRSKWKDOPLFSUREOHPLQ
a patient with respiratory illness 
symptoms, but no fever or other 
COVID-19 risk factor
• The patient can be seen in the eye clinic
• The patient should be placed in an examination lane immediately with the door closed and placed in a surgical 
mask. The treating ophthalmologist and health care personnel require surgical masks at minimum
• Gown, gloves, surgical mask and eye protection are recommended for the clinician.† An N-95 mask should be 
ZRUQLIDSURFHGXUHLVSODQQHGWKDWZLOOUHVXOWLQDHURVROL]HGYLUXV
• The examining room must be disinfected after examination
b8UJHQWRSKWKDOPLFSUREOHPbLQ
DbSDWLHQWZKRLVDWKLJKULVNIRU
COVID-19
• The patient is best sent to the ER (emergency room) or other hospital-based facility equipped to evaluate for, 
and manage, COVID-19
• If the patient has an urgent eye problem based on screening questions, the facility should be one that is 
equipped to provide eye care in the hospital setting
• ΖI6$56&R9LQIHFWLRQLVFRQȴUPHG&'&RUKRVSLWDOJXLGHOLQHVIRUFDUHRIVXVSHFWHG&29Ζ'SDWLHQWV
should be followed for health care facility preparation and infection control
• Eye care is best provided in the hospital setting. Transmission precautions‡ for treating ophthalmologists 
include wearing a surgical mask, gown, gloves and eye protection (face shield or goggles, if available)
5. Urgent ophthalmic problem in 
a patient with documented 
COVID-19 (or person under 
investigation [PUI])
• The patient should remain in the hospital setting if possible
• Determine whether the eye problem is urgent based on screening questions, and if so, evaluation and 
management should be in the hospital setting
• ΖIWKHSDWLHQWLVQRWKRVSLWDOL]HGDWWKHWLPHRIUHIHUUDOWKHSDWLHQWLVEHVWUHIHUUHGWRWKH(5RURWKHUKRVSLWDO
based facility equipped to manage both COVID-19 and eye care.
• CDC or hospital guidelines should be followed for care of COVID-19 patients.
• Transmission precautions†bIRUWUHDWLQJRSKWKDOPRORJLVWVLQFOXGHZHDULQJDQ1PDVNJRZQJORYHVDQGH\H
protection (face shield or goggles, as above).
• [Read the American College of Surgeon’s guidelines for operating on COVID-19 patients]
[Read the American College of Surgeons’ guidelines for operating on COVID-19 patients]
7DEOH AAO interim guidance on ophthalmology patient triage and precautions19
* Standard (Universal) Precautions:0LQLPXPLQIHFWLRQSUHYHQWLRQSUHFDXWLRQVWKDWDSSO\WRDOOSDWLHQWFDUHUHJDUGOHVVRIVXVSHFWHGRUFRQȴUPHGLQIHFWLRQVWDWXVRISDWLHQWLQDQ\KHDOWKFDUHVHWWLQJ
(e.g., hand hygiene, cough etiquette, use of PPE, cleaning and disinfecting environmental surfaces). See CDC: Standard Precautions. 
6XSSO\SHUPLWWLQJWLJKWȴWWLQJgoggles may be preferable to face shields for eye protection.
† Currently, there are national and international shortages of PPE, which also warrant consideration. Excessive use of PPE may deplete the supply of critical equipment required in the future for patients 
with COVID-19 as the epidemic expands. Use of PPE should be considered on an institutional and case-by-case basis; universal usage for all patient encounters is not appropriate.
‡ Transmission Precautions: Second tier of basic infection control, used in addition to Standard Precautions when patients have diseases that can spread through contact, droplet or airborne routes, 
UHTXLULQJVSHFLȴFSUHFDXWLRQVEDVHGRQWKHFLUFXPVWDQFHVRIDFDVH7UDQVPLVVLRQSUHFDXWLRQVDUHUHTXLUHGIRUFDVHVRIVXVSHFWHG&29Ζ'6HHCDC: Transmission-Based Precautions.
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COVID-19 Continued
2. Protect health care workers
Symptoms & when to self-isolate
6\PSWRPVRIFRXJKIHYHUVKRUWQHVVRIEUHDWKRUȵXOLNH
symptoms are typical in COVID-19, but others are also 
common, including loss of taste and smell.23 It is vital to 
inform patients and health care workers with symptoms 
of COVID-19 that they should not come to the hospital or 
clinic, but should self-isolate (i.e., stay at home and avoid 
contact with other members of the household) for seven 
days. The United Kingdom’s National Health Service 
(NHS) guidelines state that people who still have a high 
temperature after 7 days of self-isolation must remain at 
home until their temperature returns to normal.24
The incubation period for COVID-19 is thought to 
range from 1 to 14 days, with symptom onset typically 
around 5 days; these estimates will be updated as more 
data becomes available.4 Patients may be infectious 
before showing any symptoms, and some may 
show no symptoms at all. A person who has been 
in contact with someone known to have COVID-19 
should self-isolate for 14 days, until such time as WHO 
guidance is updated.4 It is important to follow national 
guidelines. Communicate this information to patients 
as early as possible, so that patients who need to 
VHOILVRODWHGRQRWWUDYHOWRWKHXQLWLQWKHȴUVWSODFH
)LJXUH  
Hospitals and 
clinics should have 
clear information 
for patients to 
return home and 
self-isolate if they 
have symptoms. 
UK
EL
M
IE
N
 W
O
LV
AA
RD
T
EL
M
IE
N
 W
O
LV
AA
RD
T
Disposable 
gloves 
Disposable 
plastic apron 
'LVSRVDEOHȵXLG
resistant gown 
Fluid resistant 
surgical mask 
Filtering face 
piece respirator 
Eye/face 
protection 
Slit lamp 
breath guard 
Performing an aerosol-
generating procedures (AGPs) 
Single use Single use Single use Single use 
High risk acute areas, e.g. theatres 
where AGPs performed, intensive 
care unit (ITU), high dependency 
unit (e.g. ophthalmology review 
of patient in ITU)
Single use Single use Sessional use Sessional use Sessional use 
Theatres where AGPs not done 
Single use Single use 
Risk-assess single 
use, i.e. use 
instead of apron if 
splashes are likely 
Single or 
sessional use 
Single or 
sessional use 
Working in inpatient area within 
two metres eg ophthalmology 
review of ward patients Single use Single use Sessional use Sessional use ΖIXVLQJȴ[HGslit lamp 
Emergency and acute hospital 
eye clinics 
Single use Single use Sessional use Sessional use 
Non-emergency /acute eye 
outpatients 
Single use Single use Sessional use Sessional use 
7DEOH Royal College of Ophthalmologists guidelines on protective equipment18
If they do arrive at the unit, there should be very clear 
information to prevent infection spread; e.g., telling 
patients to return home and self-isolate (Figure 1). 
Table 2 provides more detailed guidance on the type 
of PPE to be worn. It is important to take note of 
national guidelines. PPE is likely to include disposable 
gloves, disposable gown, face respirator mask (when 
appropriate, e.g., FFP3 or N95) and eye protection. Follow 
strict PPE wearing and removing procedures (see panel). 
Dispose of PPE appropriately and carry out thorough 
room cleaning and air exchange after each patient.
Single use = disposal or decontamination of device between each patient/procedure, dispose at end of session 
Sessional use = dispose at end of session, e.g. at the end of morning clinic or when leaving the care setting
Aerosol-generating procedures (AGPs). Aspects relevant to ophthalmology are in bold:
• Intubation, extubation and related procedures, such as manual ventilation and open suctioning of the respiratory tract
• Tracheotomy/tracheostomy procedures (insertion/open suctioning/removal) 
• Bronchoscopy and upper ENT airway procedures that involve suctioning 
Upper gastro-intestinal endoscopy where there is open suctioning of the upper respiratory tract
• Surgery procedures involving high-speed devices 
Some dental procedures (e.g. high-speed drilling) 
Non-invasive ventilation (e.g., CPAP and laryngeal masks)
• High-frequency oscillatory ventilation (HFOV) 
• Induction of sputum
• +LJKȵRZQDVDOR[\JHQ
How to put on and remove personal 
protective equipment (PPE)
Defer surgical procedures where possible. If surgery 
cannot be avoided, this should be done under local 
anaesthesia if possible, taking full precautions. General 
anaesthesia is an ‘aerosol-generating procedure’ 
(AGP) which creates a high-risk environment for 
virus transmission. However, even surgery under 
ORFDODQDHVWKHVLDZLOOLQYROYHVLJQLȴFDQWH[SRVXUH
between medical personnel and patient and should be 
considered high risk. If surgery must be undertaken, 
then full PPE should be used for all patients.
Self-care and personal protection
• Wash hands regularly and thoroughly; normal 
soap is adequate. Use alcohol-based (>60% ethanol 
or >70% isopropyl alcohol) hand sanitiser or hand gel 
if hands are visibly clean and water is not available.
• 6WD΍PHPEHUVDQGSDWLHQWVYLVLWRUVPXVWZDVKWKHLU
hands using soap and water or alcohol-based hand 
sanitiser or hand gel on entering the unit. 
• Avoid touching your eyes, nose and mouth.
• If available, use appropriate PPE. Guidelines are 
constantly being updated; however, there is an 
increasing recognition of the role of eye protection 
(Table 2). This is something that may be dictated by 
health management at a higher (regional/national) 
level.
• &OLQLFDOVWD΍QRWLQXQLIRUPZKRDUHLQFORVHFRQWDFW
with patients should wear surgical scrubs. These 
should be laundered daily in accordance with 
the unit’s policy on the safe laundering of clinical 
garments.
• The same surgical mask may be worn for multiple 
patients to be seen at the slit lamp. However, 
scrupulous care must be taken not to transmit the 
virus on the front of the mask via hands or clothes. 
ΖIXVLQJWKHVDPHPDVNGRQRWWDNHRQDQGR΍
between patients and do not allow it to dangle on 
the chest. Never touch the front of the mask.
• Put on and remove PPE in an order that minimises 
the potential for self-contamination (see panel).
• The use of a cloth face covering does not replace a 
surgical mask or respirator, however, they may be 
better than no covering at all.29, 30
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Correct order for putting on PPE
1 Gown/apron
2 Mask/respirator
3 Goggles/face shield
4 Gloves
Correct order for removing PPE
1 Gloves
2 Goggles/face shield
3 Gown/apron
4 Mask/respirator
5 Wash hands25
)LJXUH World Health Organization hand washing poster
3. Reduce transmission to other 
patients, and between patients and 
health care workers
A. Patient triage 
• 3DWLHQWVVKRXOGDOUHDG\KDYHEHHQQRWLȴHGQRWWR
travel to the health care unit if they have symptoms of 
COVID-19.
• Prominent information posters at the entrance to the 
unit should alert anyone who arrives to return directly 
home if they have symptoms and to stay at least 2 
metres away from others. If urgent/emergency care is 
required, they should be directed to an isolation area 
where they can be examined by health care personnel 
wearing protective equipment.
• A health care worker should ask patients about possible 
symptoms on arrival at the booking-in or reception area 
and direct them appropriately.
B. Instructions for patients
• Patients and visitors must wash their hands using soap and 
water alcohol-based (>60% ethanol or >70% isopropyl 
alcohol) hand sanitiser or hand gel on entering the unit. 
• Some countries advise that patients wear masks to limit 
transmission to medical personnel or other patients.25–28
• The use of a cloth face covering does not replace a 
surgical mask or respirator, however, they may be 
better than no covering at all.29, 30
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C. While examining the patient
• Minimise patient contact time by reviewing the notes beforehand. 
One suggestion is for the patient to be placed in one room 
and the clinician in another and for them to talk via a phone 
or a tablet computer. The clinician then enters the patient 
room, conducts the examination as swiftly as possible (without 
talking) and exits the room.
• Avoid shaking hands, or any other patient contact, as much as 
possible.
• Use slit lamp barriers (breath guards or breath shields), Figure 3. 
These may be available commercially or they can be made 
from materials such acetate sheets (used for overhead 
projectors), clear plastic or Perspex. Cut holes for the slit lamp 
eyepieces; it may help to use a cardboard template.
• 0LQLPLVHLQYHVWLJDWLRQV)RUH[DPSOHSHUIRUPYLVXDOȴHOGV
and OCT scans only if absolutely necessary. Avoid tonometry 
if possible.
• Clean surfaces and instruments between patients. Use 
disposable gloves and a solution of household bleach 
(1.5 tablespoons per litre of water) or alcohol solutions with 
at least 70% alcohol.
• Remember to clean patient seats, clinic door handles and 
phones, if used.
• 5HPHPEHUWRFOHDQWKHEUHDWKJXDUGRQR΍VZLWFKDQGDQ\
controls or buttons when cleaning the slit lamp.
D. The work environment
• Keep waiting rooms as empty as possible, with preferably at 
least 2 metres between individuals.
• Prevent overcrowding in the examination room by restricting 
entry by accompanying persons where possible.
• Routine daily cleaning of the clinic environment with appropriate 
disinfectants is vital.
Conjunctivitis Reusing eye protection
COVID-19 can cause conjunctivitis and virus particles may be 
found in ocular secretions.31
There is debate as to whether conjunctivitis is a high-risk 
feature for COVID-19. Although a follicular conjunctivitis 
can be caused by the virus, this seems to be a relatively 
XQFRPPRQDQGDQRQVSHFLȴFVLJQWKDWSUHVHQWVODWHULQ
the clinical course. However, a health care worker who 
was part of an expert task force to visit Wuhan developed 
FRQMXQFWLYLWLVDVWKHȴUVWV\PSWRPRI&29Ζ'GHVSLWH
being fully gowned with protective suit and N95 respirator.32 
Health care workers have subsequently been urged to 
wear eye protection when in close contact with patients; 
WKLVLVDOVRUHȵHFWHGLQUHFHQWO\XSGDWHGJXLGDQFH15,33 Many 
cases of conjunctivitis do not actually require review and 
it is important that patients with possible symptoms of 
COVID-19 are instructed to self-isolate unless they require 
hospital in-patient care. If a patient does present with any 
conjunctivitis, it would seem sensible to wear full PPE until 
more is known.
The CDC acknowledges that eye protection is often reusable, 
not disposable, and provides the following guidelines on 
re-use.34
When manufacturer instructions for cleaning and 
disinfection are unavailable, consider these steps:
1 While wearing gloves, carefully wipe the inside, followed 
by the outside of the face shield or goggles using a 
cleaning wipe or a clean cloth saturated with pH-neutral 
detergent solution.
2 Use a wipe or clean cloth saturated with a registered 
hospital disinfectant solution to wipe the outside of the 
face shield or goggles carefully.
3 Wipe the outside of face shield or goggles with clean 
water or 70% alcohol to remove residue.
4 Fully dry (air dry or use clean absorbent towels).
5 Remove gloves and perform hand hygiene.
)LJXUH Slit lamp breath guards
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